Phase 1b Study of Sintilimab Plus Anlotinib as First-line Therapy in Patients With Advanced NSCLC
Tianqing Chu, Runbo Zhong, Hua Zhong, Bo Zhang, Wei Zhang, Chunlei Shi, Jialin Qian, Yanwei Zhang, Qing Chang, Xueyan Zhang, Yu Dong, Jiajun Teng, Zhiqiang Gao, Huiping Qiang, Wei Nie, Yiming Zhao, Yuchen Han, Ya Chen, Baohui Han
Topics & Concepts
MedicineInternal medicineAdverse effectOncologyProgression-free survivalConfidence intervalHazard ratioGastroenterologyProgressive diseaseChemotherapyLung Cancer Research StudiesCancer Immunotherapy and BiomarkersLung Cancer Treatments and Mutations